Loading clinical trials...
Loading clinical trials...
A Feasibility Study of Tumor Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma and Merkel Cell Carcinoma
Conditions
Interventions
LN-145
Cyclophosphamide
+2 more
Locations
1
United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Start Date
February 10, 2026
Primary Completion Date
September 29, 2028
Completion Date
June 29, 2029
Last Updated
February 13, 2026
NCT06532279
NCT05969860
NCT05695222
NCT06151236
NCT06659146
NCT06947928
Lead Sponsor
Karam Khaddour, MD, MS
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions